Leadership

Our proven executive team brings deep, diverse cell therapy and oncology experience and is committed to developing safe, effective, and accessible NK cell therapies for cancer. Artiva's Board of Directors and Advisors bring years of expertise to help us realize the full potential of NK cell therapies.

Brian Daniels, M.D.

Chairman

Yong-Jun Huh

Director

Yvonne Yamanaka, Ph.D.

Director

Fred Aslan, M.D.

President, CEO and Director

Yu-Kyeong Hwang, Ph.D.

Director

Tom Farrell

Founder, CSO and Director

Laura Stoppel, Ph.D.

Director

 
  • Twitter
  • LinkedIn

Privacy Policy  |  Terms
© Artiva Biotherapeutics, Inc., 2020